ReviewCancer reports (Hoboken, N.J.)2025
Therapeutic Indications of Pembrolizumab in Eight Common Cancers: Current Evidence and Future Directions.
Raghed Mansour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it